Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT05673889 Completed - Healthy Clinical Trials

A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults

Start date: January 27, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to understand if ARV-471 affects how a medicine called, dabigatran etexilate, gets absorbed or processed into the body in healthy adults. All participants in this study will receive one dose of dabigatran etexilate alone by mouth in Period 1. In Period 2, everyone will receive one dose of dabigatran etexilate by mouth approximately 90 minutes after receiving one dose of ARV-471 by mouth. The levels of dabigatran in Period 1 will be compared to the levels of dabigatran in Period 2. This will help us to determine if and how ARV-471 affects dabigatran gets absorbed into the body differently in healthy adults. All participants will stay at the study clinic for approximately 8 days and 7 nights.

NCT ID: NCT05673174 Completed - Healthy Clinical Trials

Avicena LVDP Validation Study in Healthy Volunteers

Start date: June 16, 2022
Phase:
Study type: Observational

The purpose of this study is to document the utility of the Vivio System in quantifying LVDP in healthy volunteers.

NCT ID: NCT05667129 Completed - Healthy Clinical Trials

A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101

Start date: December 1, 2022
Phase: Phase 1
Study type: Interventional

The goal of this study is to assess the safety and tolerability of single and multiple ascending doses of XEN-101

NCT ID: NCT05665634 Completed - Healthy Clinical Trials

Concurrent TMS and EEG Pilot Study

Start date: December 2, 2022
Phase: N/A
Study type: Interventional

This study will investigate the test-retest reliability of transcranial magnetic stimulation (TMS) -evoked potentials (TEPs) as measured by electroencephalography (EEG), using three different TMS protocols over five different brain regions in healthy volunteers. The goal is to compare the test-retest reliability of single pulse, inhibitory and excitatory TMS protocols as well as two distinct targeting approaches. The main questions to answer are: 1. This study will investigate whether the test-retest reliability of TEPs differ across TMS protocols. 2. This study will investigate whether the test-retest reliability of TEPs differ between individualized and non-individualized targeting approaches.

NCT ID: NCT05664334 Completed - Healthy Clinical Trials

Safety and Immunogenicity of IVX-A12 in Healthy Older Adults

Start date: September 21, 2022
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and immunogenicity of three dosage levels (low, medium, high) of the bivalent combination respiratory syncytial virus (RSV)/human metapneumovirus (hMPV) virus-like particle (VLP) candidate vaccine (IVX-A12), compared to placebo, when administered as a single-dose regimen in healthy older adults 60 to 75 years of age.

NCT ID: NCT05661526 Completed - Healthy Clinical Trials

The Effect of Game-Based Activity on Blood Transfusion in Nursing Students

Start date: December 26, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized controlled study, which included pre-test, posttest and perseverance test, was to determine the effect of game-based learning on nursing students' knowledge levels about blood transfusion, to determine the permanence level of learning and satisfaction with the training method. The fundamental question it aims to answer is: •Does the blood transfusion training given to nursing students by the board game playing method have an effect on the level of knowledge, the permanence of the information and satisfaction with the training method? Participants will participate in an educational activity related to blood transfusion. The researchers will compare whether the blood transfusion training given to nursing students with the board game playing method is effective or not with the text-reading method.

NCT ID: NCT05661500 Completed - Healthy Clinical Trials

The Effect of Creative Drama on Postmortem Care in Nursing Students

Start date: November 4, 2022
Phase: N/A
Study type: Interventional

The goal of this randomized controlled including pretest, posttest and persistence test study is to examine the effect of creative drama method on student nurses' knowledge and skill levels related to postmortem care, learning permanence and satisfaction with the training method. The main question it aims to answer are: •Is the postmortem care training given to nursing students with the creative drama method effective on the level of knowledge and skills, the permanence of knowledge and skills and satisfaction with the training method? Participants will participate in an educational activity related to postmortem care. Researchers will compare it with the classical education method to see if postmortem care training given to nursing students with the creative drama method is effective.

NCT ID: NCT05658107 Completed - Healthy Clinical Trials

A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men

Start date: January 16, 2023
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765423 in healthy male subjects following intravenous administration of single rising doses.

NCT ID: NCT05657379 Completed - Healthy Clinical Trials

Effect of Moisturizer on Malaysian Women Facial Skin

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of Product X on facial skin of middle-aged women in Malaysia. The main questions it aims to answer are: 1. The effect of Product X on skin hydration of middle-aged women in Malaysia. 2. The effect of Product X on skin elasticity of middle-aged women in Malaysia. 3. The effect of Product X on skin wrinkle of middle-aged women in Malaysia. 4. To observe any adverse effect occurrence with the use of Product X. Participants will used Product X for 8 week and the skin assessment will be carried out at baseline, week 2, 4 and week 8.

NCT ID: NCT05654181 Completed - Healthy Clinical Trials

A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants

Start date: October 17, 2022
Phase: Phase 1
Study type: Interventional

This study is the first clinical study with PF-07328948. The safety, tolerability, and plasma pharmacokinetics and pharmacodynamics of PF-07328948 after administration of escalating, single, oral doses will be evaluated.